Personalized Medicine and Bladder Cancer with Dr. Matthew Milowsky – Episode 8
Host Rick Bangs interviews Dr. Matthew Milowsky about genetics, genomics and personalized medicine for bladder cancer treatment.
In Episode 8 of “Bladder Cancer Matters,” host Rick Bangs interviews Dr. Matthew Milowsky about genetics, genomics and personalized medicine for bladder cancer treatment.
Dr. Matthew Milowsky
Dr. Milowsky is the Section Chief, Genitourinary Oncology; Co-Director, Urologic Oncology Program University of North Carolina School of Medicine. Dr. Milowsky is also the chair of the Bladder Cancer Genomics Consortium.
In this episode, Rick and Dr. Kamat discuss:
- What the Bladder Cancer Genomics Consortium is and what it does
- What an “exceptional responder” is is bladder cancer
- The importance of clinical studies to the future of bladder cancer
- How philanthropy propels bladder cancer medical research
Related Content
